Access Vascular Logo Hi Res.png
Journal of Infusion Nursing Publishes Access Vascular Data Showing Significantly Reduced Complication Rates for HydroMID
September 19, 2022 08:00 ET | Access Vascular
BILLERICA, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
Access Vascular Logo Hi Res.png
New Access Vascular Retrospective Data Review Demonstrates Midline Catheters Composed of Advanced Biomaterials May Improve Dwell Times
July 12, 2022 08:00 ET | Access Vascular
BILLERICA, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today shared initial findings from a retrospective review of patient records that demonstrates an increase in dwell...
Access Vascular Logo Hi Res.png
Access Vascular Inc. Named 2022 MedTech Breakthrough Award Winner
May 10, 2022 08:00 ET | Access Vascular
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced it has been named “Best New Technology Solution – Drug Delivery” in the 2022 MedTech Breakthrough...
Access Vascular Logo Hi Res.png
Access Vascular Receives FDA Clearance for HydroPICC® Biomaterial-Based Dual-Lumen Catheter
May 05, 2022 11:48 ET | Access Vascular
BILLERICA, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC®...
Access Vascular Logo Hi Res.png
Access Vascular Inc. Wins 2022 Edison Award for Innovation
April 26, 2022 10:32 ET | Access Vascular
BILLERICA, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced its biomaterial-based hydrophilic catheters received a Gold Award as the 2022 Edison Best New Product...
Access Vascular Logo Hi Res.png
Access Vascular, Inc. Opens New Facility Outside Boston With Expanded Production Capacity to Meet Growing Demand for Its Biomaterial Devices
March 28, 2022 08:00 ET | Access Vascular
BILLERICA, Mass., March 28, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced the opening of its...
Vantage Market Research.png
Global Chemotherapy Devices Market to Reach USD 23.12 Billion by 2028 - Powered by Increasing Prevalence of Cancer – Vantage Market Research
February 21, 2022 02:58 ET | Vantage Market Research
WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Chemotherapy Devices Market finds that increasing prevalence of cancer is expediting market...
Access Vascular Logo Hi Res.png
Access Vascular Inc. Partners with Healthcare Insights to Develop New MedTech Value-Based Care Program
February 10, 2022 08:00 ET | Access Vascular
BILLERICA, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), today announced its partnership with Healthcare Insights (HCIS) to build a value-based care program that can more...
Access Vascular Logo Hi Res.png
Access Vascular Inc. Named 2022 BIG Innovation Award Winner
January 11, 2022 12:44 ET | Access Vascular
BEDFORD, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) --  Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced it has been named a...
Access Vascular Logo Hi Res.png
Access Vascular Inc. and Eloquest Healthcare Partner to Improve Vascular Access Outcomes
October 27, 2021 08:00 ET | Access Vascular
BEDFORD, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced it has formed a...